Jump to content

Search the Community

Showing results for tags 'germany'.

More search options

  • Search By Tags

    Type tags separated by commas.
  • Search By Author

Content Type


  • Discussions
    • Polio
    • Flu awareness
    • European Immunization Week, 23–29 April 2018
    • Migration and immunization
    • World Hepatitis Day, 28 July 2017
    • European Immunization Week, 24 - 30 April 2017
    • General discussions
    • Education on Immunization
    • Data visualization
    • About NITAGs
    • Research papers, articles, and reports
    • News and social media
    • Updates from partners and stakeholders
    • European Immunization Week (2016)
    • Job opportunities
    • Q&A about the site
    • Innsbruck Treffen (private forum)


  • European Immunization Week 2018
    • Planning resources - EIW 2018
    • Brochures - EIW 2018
    • Infographics - EIW 2018
    • Posters - EIW 2018
    • Banners and social media - EIW 2018
    • Meeting folders - EIW 2018
  • Flu Awareness - 2017
    • Flu Awareness Campaign Posters
  • European Immunization Week 2017
    • Planning resources - EIW 2017
    • Brochures - EIW 2017
    • Infographics - EIW 2017
    • Posters - EIW 2017
    • Banners and social media - EIW 2017
    • Meeting folders - EIW 2017
  • Flu Awareness - 2016
    • Flu Awareness Campaign Posters
  • EIW 2016
    • Planning resources
    • Posters
    • Meeting folders

Find results in...

Find results that contain...

Date Created

  • Start


Last Updated

  • Start


Filter by number of...


  • Start



About Me





Found 18 results

  1. Bavarian Immunization Week - Information booth in Nuernberg
  2. Bavarian Immunization Week - Information booth in Munich.
  3. Measles outbreaks continue to occur in a number of EU/EEA countries, and there is a risk of spread and sustained transmission in areas with susceptible populations. Since the beginning of 2016, 48 deaths due to measles were reported in the EU. New data published today by ECDC in the Communicable Disease Threat Report (CDTR) show that the highest number of measles cases in 2017 were reported in Romania (7 977), Italy (4 854) and Germany (904). Greece is currently experiencing a measles outbreak, with 690 cases including two deaths, reported since May 2017; most cases were unvaccinated or incompletely vaccinated. The monthly measles and rubella surveillance monitoring report is also published today and provides more in-depth analysis of the situation. The spread of measles across Europe is due to suboptimal vaccination coverage in many EU/EEA countries: of all measles cases reported during the one-year period 1 November 2016‒31 October 2017 with known vaccination status, 87% were not vaccinated. Measles increasingly affects all age groups across Europe and in 2017, 45% of measles cases with known age were aged 15 years or older. Romania, Italy, Germany and Greece were the countries most affected by measles during 2016 and 2017 and each shows different trends: Romania saw a sharp increase in cases from October 2016, and the trend has continued throughout 2017; in Italy, the increasing trend started in January 2017, while in Germany it began in February 2017; Greece has seen a measles outbreak starting in the second half of 2017, with 167 cases reported in October. This data is based on analysis of the cases notified to ECDC and included in the monthly and biannual monitoring reports. The latest available figures on vaccination coverage collected by WHO (2016) show that the vaccination coverage for the first dose of measles was below 95% in 18 of 30 EU/EEA countries; for the second dose of measles, it was below 95% in 20 of 27 EU/EEA countries reporting second dose coverage data. In order to achieve the measles elimination goal, the vaccination coverage rates for children targeted by routine vaccination programmes should increase in a number of countries, as the vaccination coverage of the second dose must be at least 95% to interrupt measles circulation and achieve herd immunity. This is particularly important to protect children below one year of age, who are particularly vulnerable to complications of measles but are too young to have received the first dose of vaccine. Read more ECDC collects measles data on a monthly basis via The European Surveillance System (TESSy). In addition, ECDC monitors measles and rubella epidemiology and outbreaks via epidemic intelligence. For a complete overview of data regarding measles outbreaks in the EU/EEA in 2016 and 2017, the following outputs are available and regularly updated: Communicable Disease Threat Report “Measles and Rubella, Monitoring European and worldwide outbreaks” (Epidemic intelligence data) Monthly measles and rubella monitoring report (a concise report with TESSy data from 1 November 2016 – 31 October 2017) Bi-annual measles and rubella monitoring report (an extensive report, TESSy and epidemic intelligence data presented, with data from 1 January 2016 – 30 June 2017) ECDC Atlas of Infectious Diseases (TESSy data) Monthly-Measles-Rubella-monitoring-report-December-2017_0.pdf
  4. Germany conference: Dr Günter Pfaff (Chair of the Regional Verification Commission for Measles and Rubella Elimination) and Dr Mark Muscat (Technical Officer) at a stand distributing European Immunization Week 2017 material at the National Public Health Congress in Munich, Germany on 3-5 May 2017

    © WHO EURO

  5. Dr Mark Muscat talking about the state of measles at the WHO European Region at the National Public Health Congress in Munich, Germany on 5 May 2017.

    © WHO EURO

  6. until
    Please see attached file. Overview_EIW2017_activities in Germany.pdf
  7. Videos explaining the measles vaccination recommendations for children and adults. http://www.impfen-info.de/mediathek/filme/

    © Federal Centre for Health Education - Germany

  8. The tool shows age specific measles vaccination rates for each administrative district in Germany. www.vacmap.de

    © Robert Koch Institut

  9. This article analyses the work plans of 5 european NITAGs between 2011 and 2014 to identify overlapping topics and similar processes. It aims to identify areas of collaboration between these committees - a burning issue at a time of the Global NITAG Network! http://www.sciencedirect.com/science/article/pii/S0264410X16310362 1-s2.0-S0264410X16310362-main.pdf
  10. In September 2016, STIKO, the German NITAG, launched its own app, the first of its kind in the NITAG community. Anyone can download the app, which is compatible with Android or IOS, and access all STIKO’s recommendations. “This innovative digital project aims to strengthen relationships between healthcare workers and STIKO,” explain Ole Wichmann and Judith Koch from Robert Koch Institute. Why an application? STIKO is slightly different from other NITAGs. The committee does not advise the Ministry of Health, but its recommendations are regarded as good medical practice guidelines and help decide if a vaccine will be reimbursed by insurance companies. STIKO recommendations are almost always implemented, but several studies on barriers and enablers to vaccination in Germany showed how important it is to actively engage with physicians. Medical professionals are the key to engaging the population and the main drivers to promote vaccination. For the past few years, STIKO has been evaluating opportunities to improve communication with private physicians (where the majority of vaccinations are implemented), and the increasing number of them using tablets and smartphones in their daily work life encouraged us to develop an app. How did you develop it? We published a call for tender and the publisher Börm Bruckmeyer, who has experience in developing medical apps, convinced us. Three people from the immunization unit at the Robert Koch Institute got involved, and we also appealed to the IT department to help with the algorithm. Altogether, the whole process took about a year, from design to launch. What can be found in this app? All recommendations issued by STIKO, and published annually in the Epidemiological bulletin of the Robert Koch Institute, are fully reproduced. Instruction leaflets for all vaccines and FAQs for vaccination are also available on the app’s home screen, as well as up-to-date information on supply bottlenecks or new STIKO recommendations and opinion papers. Why would a NITAG want to communicate its recommendations? The stakes are high when promoting our recommendations to all healthcare workers. Well informed physicians will be better equipped to talk to their patients and so improve the acceptance of vaccination, which will in turn increase vaccination rates. source:http://www.nitag-resource.org/news-and-events/news/95-digital-communication-for-nitags-is-no-longer-optional
  11. STIKO (The NITAG of Germany) recommends to use either the nasal vaccine ( LAIV) or an inactivated vaccine (IIA) in the coming season 2016/2017 for children aged from 2-17 years. 39_16_STIKO-Stellungnahme.pdf
  12. We launched a crossword to draw the attention of health care workers to EIW: http://impfbrief.de/index.php?nav=5#id202 crossword (in German): https://www.xwords-generator.de/de/s/emp74 crossword generator: https://www.xwords-generator.de Has anybody else a similar idea? We would like to try more approaches of this kind.
  13. "Talkshow" with different experts and vaccine opponents performed by junior high school students in Ludwigsburg, Germany. The 35min play was followed by a discussion forum in front of approximately 150 students and several teachers.
  14. In a new study, researchers in Hanover, Germany, analyzed data showing that the prevalence of hepatitis B is higher among refugees than the general German population, but not higher than the immigrants who already live in Germany. The good news is that the system for vaccination is pretty strong in Germany, with a high ability to vaccinate for hepatitis B, or other diseases like tuberculosis, and measles/mumps/rubella. See the full article.
  • Create New...